MoneyWorks4Me

The revenue declined to Rs. 5145.40 millions for the quarter ended December 2024 as compared to Rs. 5382.10 millions during the corresponding quarter last year.A humble growth in net profit of 21.85% reported in the quarter ended December 2024 to Rs. 385.30  millions from Rs. 316.20 millions.The company reported a good operating profit of 716.20 millions compared to 614.20 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 5145.40 5382.10 -4.40 15505.90 17073.80 -9.18 22669.10 24979.70 -9.25
Other Income 113.70 16.80 576.79 118.60 30.70 286.32 41.80 22.30 87.44
PBIDT 716.20 614.20 16.61 1858.70 2001.40 -7.13 2703.10 2846.30 -5.03
Interest 75.70 67.50 12.15 222.00 220.70 0.59 301.60 325.30 -7.29
PBDT 640.50 546.70 17.16 1636.70 1780.70 -8.09 2401.50 2521.00 -4.74
Depreciation 120.20 118.00 1.86 355.90 353.30 0.74 476.70 472.90 0.80
PBT 520.30 428.70 21.37 1280.80 1427.40 -10.27 1924.80 2048.10 -6.02
TAX 135.00 112.50 20.00 322.50 370.00 -12.84 506.00 520.00 -2.69
Deferred Tax 15.00 5.00 200.00 40.00 25.00 60.00 10.00 -12.50 -180.00
PAT 385.30 316.20 21.85 958.30 1057.40 -9.37 1418.80 1528.10 -7.15
Equity 912.70 919.40 -0.73 919.40 926.00 -0.71 919.40 926.00 -0.71
PBIDTM(%) 13.92 11.41 21.97 11.99 11.72 2.26 11.92 11.39 4.65
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..